BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muraresku CC, McCormick EM, Falk MJ. Mitochondrial Disease: Advances in clinical diagnosis, management, therapeutic development, and preventative strategies. Curr Genet Med Rep 2018;6:62-72. [PMID: 30393588 DOI: 10.1007/s40142-018-0138-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Elander J, McCormick EM, Värendh M, Stenfeldt K, Ganetzky RD, Goldstein A, Zolkipli-Cunningham Z, MacMullen LE, Xiao R, Falk MJ, Ehinger JK. Pathogenic mtDNA variants, in particular single large-scale mtDNA deletions, are strongly associated with post-lingual onset sensorineural hearing loss in primary mitochondrial disease. Mol Genet Metab 2022;137:230-8. [PMID: 36182714 DOI: 10.1016/j.ymgme.2022.09.002] [Reference Citation Analysis]
2 Yu T, Wang Y, Yuan K, Guo Q, Ge J. Electrochemical immunosensor with PVP/WS2 nanosheets electrode for fibroblast growth factor 21 detection based on metal organic framework nanozyme. Sensors and Actuators B: Chemical 2022;367:132056. [DOI: 10.1016/j.snb.2022.132056] [Reference Citation Analysis]
3 Maglioni S, Schiavi A, Melcher M, Brinkmann V, Luo Z, Laromaine A, Raimundo N, Meyer JN, Distelmaier F, Ventura N. Neuroligin-mediated neurodevelopmental defects are induced by mitochondrial dysfunction and prevented by lutein in C. elegans. Nat Commun 2022;13:2620. [PMID: 35551180 DOI: 10.1038/s41467-022-29972-4] [Reference Citation Analysis]
4 Aldossary AM, Tawfik EA, Alomary MN, Alsudir SA, Alfahad AJ, Alshehri AA, Almughem FA, Mohammed RY, Alzaydi MM. Recent Advances in Mitochondrial Diseases: from Molecular Insights to Therapeutic Perspectives. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.05.011] [Reference Citation Analysis]
5 Li Y, Li S, Qiu Y, Zhou M, Chen M, Hu Y, Hong S, Jiang L, Guo Y. Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children. Front Pediatr 2022;10:851534. [DOI: 10.3389/fped.2022.851534] [Reference Citation Analysis]
6 Karaa A, Macmullen LE, Campbell JC, Christodoulou J, Cohen BH, Klopstock T, Koga Y, Lamperti C, Maanen R, Mcfarland R, Parikh S, Rahman S, Scaglia F, Sherman AV, Yeske P, Falk MJ. Community Consensus Guidelines to Support FAIR Data Standards in Clinical Research Studies in Primary Mitochondrial Disease. Advanced Genetics 2022;3:2100047. [DOI: 10.1002/ggn2.202100047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Acin-Perez R, Benincá C, Shabane B, Shirihai OS, Stiles L. Utilization of Human Samples for Assessment of Mitochondrial Bioenergetics: Gold Standards, Limitations, and Future Perspectives. Life (Basel) 2021;11:949. [PMID: 34575097 DOI: 10.3390/life11090949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zanfardino P, Doccini S, Santorelli FM, Petruzzella V. Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain. Int J Mol Sci 2021;22:8325. [PMID: 34361091 DOI: 10.3390/ijms22158325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fan SP, Hsueh HW, Huang HC, Chang K, Lee NC, Huang PH, Yang CC. Lactate peak in muscle disclosed by magnetic resonance spectroscopy in a patient with CPEO-plus syndrome. eNeurologicalSci 2021;24:100360. [PMID: 34377843 DOI: 10.1016/j.ensci.2021.100360] [Reference Citation Analysis]
10 Tolomeo D, Orsucci D, Nesti C, Baldacci J, Battini R, Bruno C, Bruno G, Cassandrini D, Doccini S, Donati MA, Ferrari A, Fiori S, Fiorillo C, Guerrini R, Mari F, Montomoli M, Pochiero F, Procopio E, Ruggiero L, Sampaolo S, Sicca F, Ticci C, Rubegni A, Santorelli FM. The Diagnostic Approach to Mitochondrial Disorders in Children in the Era of Next-Generation Sequencing: A 4-Year Cohort Study. J Clin Med 2021;10:3222. [PMID: 34362006 DOI: 10.3390/jcm10153222] [Reference Citation Analysis]
11 Jett KA, Baker ZN, Hossain A, Boulet A, Cobine PA, Ghosh S, Ng P, Yilmaz O, Barreto K, Decoteau J, Mochoruk K, Ioannou GN, Savard C, Yuan S, Lowden C, Kim B, Cheng HM, Battersby BJ, Gohil VM, Leary SC. Mitochondrial dysfunction triggers secretion of the immunosuppressive factor α-fetoprotein.. [DOI: 10.1101/2021.07.02.450924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Souren T, Rose E, Groepenhoff H. Comparison of Two Metabolic Simulators Used for Gas Exchange Verification in Cardiopulmonary Exercise Test Carts. Front Physiol 2021;12:667386. [PMID: 34149449 DOI: 10.3389/fphys.2021.667386] [Reference Citation Analysis]
13 Guha S, Mathew ND, Konkwo C, Ostrovsky J, Kwon YJ, Polyak E, Seiler C, Bennett M, Xiao R, Zhang Z, Nakamaru-Ogiso E, Falk MJ. Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C. elegans and zebrafish models of mitochondrial complex I disease. Hum Mol Genet 2021;30:536-51. [PMID: 33640978 DOI: 10.1093/hmg/ddab059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Smith M. Neurodevelopmental, neurocognitive, and behavioral disorders. Mechanisms and Genetics of Neurodevelopmental Cognitive Disorders 2021. [DOI: 10.1016/b978-0-12-821913-3.00007-x] [Reference Citation Analysis]
15 Ikawa M, Okazawa H, Nakamoto Y, Yoneda M. PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction. Antioxidants (Basel) 2020;9:E861. [PMID: 32937849 DOI: 10.3390/antiox9090861] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
16 Garrido-Pérez N, Vela-Sebastián A, López-Gallardo E, Emperador S, Iglesias E, Meade P, Jiménez-Mallebrera C, Montoya J, Bayona-Bafaluy MP, Ruiz-Pesini E. Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome. Int J Mol Sci 2020;21:E3374. [PMID: 32397676 DOI: 10.3390/ijms21093374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Maglioni S, Schiavi A, Melcher M, Brinkmann V, Luo Z, Laromaine A, Raimundo N, Meyer JN, Distelmaier F, Ventura N. Neuroligin-mediated neurodevelopmental defects are induced by mitochondrial dysfunction and prevented by lutein in C. elegans.. [DOI: 10.1101/2020.02.20.957225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Guha S, Konkwo C, Lavorato M, Mathew ND, Peng M, Ostrovsky J, Kwon YJ, Polyak E, Lightfoot R, Seiler C, Xiao R, Bennett M, Zhang Z, Nakamaru-Ogiso E, Falk MJ. Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease. Hum Mol Genet 2019;28:1837-52. [PMID: 30668749 DOI: 10.1093/hmg/ddz023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
19 Iakovenko EV, Fedotova EY, Illarioshkin SN. Progressive external ophthalmoplegia. РНЖ 2020;24:4-13. [DOI: 10.30629/2658-7947-2019-24-6-4-13] [Reference Citation Analysis]
20 Kaneva K, Merkurjev D, Ostrow D, Ryutov A, Triska P, Stachelek K, Cobrinik D, Biegel JA, Gai X. Detection of mitochondrial DNA variants at low level heteroplasmy in pediatric CNS and extra-CNS solid tumors with three different enrichment methods. Mitochondrion 2020;51:97-103. [PMID: 31972374 DOI: 10.1016/j.mito.2020.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Chinnery PF, Horvath R. Mitochondrial disorders due to mutations in the nuclear genome. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease 2020. [DOI: 10.1016/b978-0-12-813955-4.00028-3] [Reference Citation Analysis]
22 Falk MJ, Shen L, Gai X. Mitochondrial Disease Genes Compendium: connecting with knowledge in the Mitochondrial Disease Sequence Data Resource (MSeqDR). Mitochondrial Disease Genes Compendium 2020. [DOI: 10.1016/b978-0-12-820029-2.00002-4] [Reference Citation Analysis]
23 Blank AC, Breur JMPJ, Fuchs SA, Koop K, Baas AF. Mitochondrial Cardiomyopathies. Clinical Cardiogenetics 2020. [DOI: 10.1007/978-3-030-45457-9_11] [Reference Citation Analysis]
24 Thorburn DR. The history and evolving paradigm for genomic diagnosis of mitochondrial diseases. Mitochondrial Disease Genes Compendium 2020. [DOI: 10.1016/b978-0-12-820029-2.00001-2] [Reference Citation Analysis]
25 Watson E, Ahmad K, Fraser CL. The neuro-ophthalmology of inherited myopathies. Current Opinion in Ophthalmology 2019;30:476-83. [DOI: 10.1097/icu.0000000000000610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 McCormick EM, Zolkipli-Cunningham Z, Falk MJ. Mitochondrial disease genetics update: recent insights into the molecular diagnosis and expanding phenotype of primary mitochondrial disease. Curr Opin Pediatr 2018;30:714-24. [PMID: 30199403 DOI: 10.1097/MOP.0000000000000686] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
27 Triska P, Kaneva K, Merkurjev D, Sohail N, Falk MJ, Triche TJ Jr, Biegel JA, Gai X. Landscape of Germline and Somatic Mitochondrial DNA Mutations in Pediatric Malignancies. Cancer Res 2019;79:1318-30. [PMID: 30709931 DOI: 10.1158/0008-5472.CAN-18-2220] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
28 Kanungo S, Morton J, Neelakantan M, Ching K, Saeedian J, Goldstein A. Mitochondrial disorders. Ann Transl Med 2018;6:475. [PMID: 30740406 DOI: 10.21037/atm.2018.12.13] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]